Tissue-conserving surgery for prognosis, treatment, and function preservation

Laryngoscope

Volumn 108, Issue 11, 1998, Pages 1599-1604

  Schuller, David E ^a   Bier Laning, Carol M ^a   Sharma, Pramod K ^a   Siegle, Ronald J ^a   Karanfilov, Boris ^a   Miller, Ryan ^a   Pellegrini, Arthur E ^b   Young, Donn C ^b  

^a Neck Oncology Program   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MALE; MOUTH CANCER; NECK DISSECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0031773748     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199811000-00003     Document Type: Article

References (29)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics: 1994. CA Cancer J Clin 1994;44:7-26.
2. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994;265:415-7.
3. Zhang S-Y, Klein-Szanto AJP, Sauter ER, et al: Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 1994;54:5050-3.
4. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56:3630-3.
5. Tobin E, Weghorst C, Borchers J, et al. Expression of tumor suppressor genes p16 and RB in squamous cell carcinoma of the head and neck. Fourth International Conference on Head and Neck Cancer. Toronto, Canada; 1996:142:94.
6. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993;53:4477-80.
7. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-35.
8. Lucas JM, Mountain RE, Gramza AW, Schuller DE, Wilkie NM, Lang JC. Expression of cyclin D1 in squamous cell carcinomas of the head and neck. Int J Oncol 1994;5:469-72.
9. Michalides R, vanVeelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
10. Kotelnikov VM, Coon JS IV, Mundle S, et al. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res 1997;3:95-101.
11. Gluckman JL, Pavelic ZP, Welkoborsky H-J, et al. Prognostic indicators for T1 squamous cell carcinoma of the oral cavity: a clinical pathologic correlation. Laryngoscope 1997 (in press).
12. Davidson TM, Haghighi P, Astarita R, Baird S, Seagren S. Microscopically oriented histologic surgery for head and neck mucosal cancer. Cancer 1987;60:1856-61.
13. Davidson TM, Haghighi P, Astarita R, Baird S, Seagren S. Mohs for head and neck mucosa cancer: report on 111 patients. Laryngoscope 1988;98:1078-83.
14. Looser KG, Shah JP, Strong EW. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg 1978;1:107-11.
15. Vikram B, Strong EW, Shah JP, Spiro R. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 1984;6:720-3.
16. Chen TY, Emrich LJ, Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys 1987;13:833-7.
17. Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong WE. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986;152:345-50.
18. Mohit-Tabatabai MA, Sobel HJ, Rush BF, Mashberg A. Relation of thickness of floor of mouth stage I and II cancers to regional metastasis. Am J Surg 1986;152:351-3.
19. Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 1994;168:373-80.
20. Houck JR, Medina JE. Management of cervical lymph nodes in squamous carcinomas of the head and neck. Sem Surg Oncol 1995;11:228-39.
21. Alvi A, Johnson JT. Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg 1996;114:65-70.
22. Leemans CR, Tiwari R, Nauta JJP, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994;73:187-90.
23. Crissman JD, Liu WY, Gluckman JL, Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 1984;54:2995-3001.
24. McGavran MH, Bauer WC, Ogura JH. The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer 1961;14:55-66.
25. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg 1985;150:414-21.
26. Spiro JD, Spiro RH, Shah JP, Sessions RB. Critical assessment of supraomohyoid neck dissection. Am J Surg 1988;156:286-9.
27. van den Brekel MWM, Snow GB. Assessment of lymph node metastases in the neck. Oral Oncol Eur J Cancer 1994;30B:88-92.
28. Schuller DE, Mountain RE, Nicholson RE, Bier-Laning CM, Powers B, Repasky M. One-stage reconstruction of partial laryngopharyngeal defects. Laryngoscope 1997;107:247-53.
29. Urken ML, Blackwell K, Biller HF. Reconstruction of the laryngopharynx after hemicricoid/hemithyroid cartilage resection: preliminary functional results. Arch Otolaryngol Head Neck Surg 1997;123(11):1213-22.